Description
AI-Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges is a definitive reference exploring the transformative influence of Artificial Intelligence (AI) in neuro and cardiovascular drug delivery. This book integrates cutting-edge research to explain how AI is poised to reshape clinical protocols, therapeutic strategies, and regulatory standards. By examining advancements in robotics and intelligent systems, it demonstrates how AI enhances precision, personalization, and efficiency in drug delivery for heart and neurological conditions, providing readers with a thorough understanding of these innovations and their potential to revolutionize healthcare practices.The book delves into AI-driven drug design and testing for cardiovascular diseases and explores the application of AI in cardiac drug delivery vehicles. It discusses bioengineered heart and vessel therapeutics, redox homeostasis, and targeted drug replenishment in cardiac matrix remodeling. Additionally, it addresses mitochondrial drug retention, AI-assisted gene therapy for neurodegenerative disorders, and the role of AI in optimizing heart health. The text highlights smart systems for managing cerebrovascular accidents and neuromodulation with pharmacotherapy. Finally, it covers translational challenges, future directions, and the significance of AI-driven prediction models and robotic delivery mechanisms.- Explores AI's role in personalized drug regimens for neuro and cardiovascular diseases- Offers insights into AI-enhanced drug design and testing methodologies- Discusses advanced robotic delivery systems for targeted, efficient drug administration- Provides guidelines for integrating AI into clinical practices- Enhances understanding of AI-driven prediction models for optimizing patient outcomes
Table of Contents
1. IntroductionSection I: Fundamentals and concepts2. AI and ML in translational drug delivery.3. Current AI practices in the management of cardiovascular and neurological diseases.4. AI-enhanced drug design and testing for cardiovascular diseases.Section II: AI-supported drug delivery5. Artificial intelligence in cardiac drug delivery vehicles6. Bioengineered heart and vessels: Insights on AI-based drug release approaches.7. AI-inspired redox homeostasis of cardiovascular system: Next-gen drug therapy8. AI-targeted drug replenishment in cardiac matrix remodeling and regeneration.9. Mitochondrial drug retention: Novel avenues in AI10. AI-assisted pharmaco and gene therapy for neurodegenerative diseases11. Neuromodulation with pharmacotherapy: An AI perspectiveSection III: Management and future12. AI in Heart Health13. Augmented optimization of medical side effects – avoiding the crisis of complication.14. Smart systems for the management of cerebrovascular accidents.15. Translational challenges and future.
